<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-657DNHX4</identifier><date>2020</date><creator>Česen, Maja</creator><creator>Jazbec, Janez</creator><relation>documents/doc/6/URN_NBN_SI_doc-657DNHX4_001.pdf</relation><relation>documents/doc/6/URN_NBN_SI_doc-657DNHX4_001.txt</relation><format format_type="issue">4</format><format format_type="volume">54</format><format format_type="type">article</format><format format_type="extent">str. 455-460, VIII</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">48468483</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-657DNHX4</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">mladostniki</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">otroci</subject><subject language_type_id="slv">preživetje</subject><subject language_type_id="slv">rabdomiosarkom</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">zdravljenje</subject><title>Treatment of rhabdomyosarcoma in children and adolescent from four low health expenditures average rates countries</title></Record>